UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

The Reserve Bank of Australia has named the fintechs and banks participating in a series of digital money and crypto asset trials later this year under Project Acacia, which has received regulatory ...

A panel at CTO East Coast discussed the regulatory changes impacting oncology trials and how these can be managed.

Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and regulations.

New regulations for running clinical trials in the UK have now been signed into law. A 12-month roll-out begins 11th April to deliver the most significant update to UK clinical trials regulation in ...

The U.K. is rolling out new regulations meant to reduce red tape for clinical studies and boost the nation’s role in international trials. The law, an update of the Medicines for Human Use ...

New UK clinical trials regulations have been signed into law, with a 12-month rollout starting 11 April. The reforms mark the most significant update in 20 years, aiming to enhance participant safety, ...

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

To avoid overlaps, the industry is calling for aligning MDR/IVDR with the EU's digital frameworks, pharmaceutical regulations, and clinical trial regulations.